OCULUS INNOV SCI (NASDAQ:OCLS)

1.40

0.03 (2.1%)

OCULUS INNOV SCI (NASDAQ:OCLS) Delayed :
Previous Close	$1.43	52 Week High	$5.75
Open	$1.42	52 Week Low	$0.35
Day High	$1.49	P/E	N/A
Day Low	$1.40	EPS	$-0.59
Volume	100,053
More OCLS Info: Chart SEC Filings Profile Historical Options

What is this?Friends, Peers and Foes

Ticker	# Stories	Ticker	# Stories
NVAX	3	EZPW	3
SNIC	3	GM	3
SWHC	3	CTIC	3
SVNT	2	ZZ	2
OSTE	2	APPY	2
GOK	2	BGP	2

View All Entities

Jun 12, 2009 08:51 AM Oculus Innovative Sciences (OCLS) Reports Q4 Loss of $0.13
May 27, 2009 08:41 AM Oculus Innovative (OCLS) Receives FDA 510(k) Okay

Nov 6, 2009 01:44 PM Unusual 11 Mid-Day Movers 11/06: CBBO, OPTT, GROW, MGA Higher; GOK, OSTE, NHWK, OCLS Lower
Nov 4, 2009 02:42 PM Trading Radar for 11/05: Starbucks (SBUX), CBS Corp. (CBS), CVS (CVS), Toyota (TM), Thomson Reuters (TRI)
Sep 16, 2009 08:26 AM Oculus Innovative (OCLS) In Strategic Partnership with V&M Industries
Sep 10, 2009 09:59 AM Morning Movers 9/10: DVAX, DARA, GNBT, XRTX, NCS Higher; PLAB, SEH, NAV Lower
Sep 10, 2009 08:22 AM Oculus Innovative Sciences (OCLS) Receives Medicare HCPCS Code for Reimbursement of Microcyn Skin & Wound HydroGel

Nov 13, 2009 08:08AM Oculus Innovative Sciences' Development Partner, Bayer Animal Health, Receives Regulatory Approvals to Market Microcyn(R)-Based Vetericyn(TM) Animal Healthcare Products in China and Taiwan
Nov 5, 2009 04:05PM Oculus Innovative Sciences Reports Second Quarter FY 2010: 60% Reduction in Operating Expenses and 16% Increase in Product Revenue (37% in Local Currency)
Oct 22, 2009 08:08AM Oculus Innovative Sciences Announces Fiscal Second Quarter 2010 Financial Results and Corporate Update Release and Conference Call
Sep 28, 2009 08:45AM Oculus Innovative Sciences Rolls Out Microcyn(R) HydroGel Skin and Wound Care Products for Both U.S. Healthcare Professionals and Consumers

Nov 17, 2009 04:01 AM Oculus Wins China Approval for Animal Wound Product
Aug 21, 2009 02:22 PM Oculus's New Product Can Tap into Several Billion Dollar Markets
Aug 18, 2009 04:28 PM Closing Update for Tuesday, August 18: Some Recouping
Aug 17, 2009 05:40 PM Positive News Ahead for Oculus Innovative Sciences
Jul 13, 2009 04:19 PM Closing Update for Monday, June 13

Jessica
on Jun 22, 2009
at 10:44 PM Acne Niacinamide (Vitamin B3) applied topically, is beneficial for reducing Acne, Skin hyper-pigmentation (acne scars), increasing skin moisture and reducing fine wrinkles. Scientists at NY University College of Medicine have shown that Niacinamide is superior to antibiotics such as Clindamycin in controlling acne. Try "Niapads" (it contains Niacinamide) for controlling your acne. It’s Simple for Pimple(C). One step process provides exfoliation, pore cleansing, prevention of Acne and Skin Lightening (acne scars). Visit www.niapads.com for details. Free shipping to all US and Canada.
Article: Oculus Innovative (OCLS) Announces "Highly Encouraging" Results From Feasibility Study of Microcyn Hydrogel

No comments are currently available.